Skip to main content
Premium Trial:

Request an Annual Quote

BioNanomatrix Changes Name to BioNano Genomics

Premium

BioNanomatrix has changed its name to BioNano Genomics, the company said this week.

Through the name change, the firm wants to communicate "its position as a solution provider for genomics researchers."

The company, originally based in Philadelphia but now headquartered in San Diego, has been developing a nanochannel platform, called NanoAnalyzer, to visualize single molecules of DNA. Its first applications are expected to be in de novo genome assembly and in structural variation analysis.

Earlier this year, BioNano Genomics raised $23.3 million in a Series B financing round, appointed a new president and CEO, and moved its headquarters (IS 6/21/2011).

It plans to launch the NanoAnalyzer commercially in 2012.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.